BYU team devises method to speed up vaccine production

Brigham Young University researchers have developed a "just add water" method to expedite vaccine production in the face of new viruses. The process, published in Biotechnology Journal, involves creating vaccine production machinery en masse and then freeze-drying it and stockpiling it in different locations. In the event the vaccines are needed when a virus hits, labs can add water to produce the vaccines quickly, the researchers said. Release | Abstract

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

The partnership aims to make the production of vaccines that use adenovirus as vectors more cost-effective and contamination-free.